King Fahad Medical City - BioBank Department, Saudi Arabia
Objective: 1. Through dedication, learning, growth, modern technology and knowledge, King Fahad Medical City Biobank will retain the biological material and clinical data safely and securely to be used in translational studies and targeted therapy that impact health outcomes. It will focus mainly on the most common ten solid cancers, most of leukemia and lymohoma in Saudi Arabia. Due to high frequency of many metabolic syndromes, they will be part of our focus 2. Contribute toward healthy citizens by sharing information and biological material and data with other healthcare and research facilities. This include many governmental institutes that are not under the umbrella of Ministry of Health 3. To be a center of excellence for training and education in Biobank at Ministry of Health Level.
|Registered Biobank Name||King Fahad Medical City - BioBank Department|
|Biobank Leader||Mosa Fagih|
|Email for biobank inquiries||mfageeh@KFMC.med.sa|
|Principal Investigator||Mosa Ali Fagih|
||Poly - Collection aimed at supporting undetermined, multiple users with ethics approved research projects, through a defined access/application mechanism.|